首页> 美国卫生研究院文献>Computational and Structural Biotechnology Journal >MetaCancer: A deep learning-based pan-cancer metastasis prediction model developed using multi-omics data
【2h】

MetaCancer: A deep learning-based pan-cancer metastasis prediction model developed using multi-omics data

机译:MetAcancer:使用多OMICS数据开发的深基于学习的泛癌转移预测模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Predicting metastasis in the early stages means that clinicians have more time to adjust a treatment regimen to target the primary and metastasized cancer. In this regard, several computational approaches are being developed to identify metastasis early. However, most of the approaches focus on changes on one genomic level only, and they are not being developed from a pan-cancer perspective. Thus, we here present a deep learning (DL)–based model, MetaCancer, that differentiates pan-cancer metastasis status based on three heterogeneous data layers. In particular, we built the DL-based model using 400 patients’ data that includes RNA sequencing (RNA-Seq), microRNA sequencing (microRNA-Seq), and DNA methylation data from The Cancer Genome Atlas (TCGA). We quantitatively assess the proposed convolutional variational autoencoder (CVAE) and alternative feature extraction methods. We further show that integrating mRNA, microRNA, and DNA methylation data as features improves our model's performance compared to when we used mRNA data only. In addition, we show that the mRNA-related features make a more significant contribution when attempting to distinguish the primary tumors from metastatic ones computationally. Lastly, we show that our DL model significantly outperformed a machine learning (ML) ensemble method based on various metrics.
机译:预测早期阶段的转移意味着临床医生有更多的时间来调整治疗方案以靶向初级和转移癌症。在这方面,正在开发几种计算方法以尽早识别转移。然而,大多数方法仅关注一个基因组水平的变化,并且它们不是从泛癌症的角度发展的。因此,我们在这里提出了一种基于三个异构数据层的泛癌转移状态的深度学习(DL)的模型,称为泛癌转移状态。特别是,我们使用400名患者数据建立了基于DL的模型,该数据包括来自癌症基因组Atlas(TCGA)的RNA测序(RNA-SEQ),MicroRNA测序(MicroRNA-SEQ)和DNA甲基化数据。我们定量评估所提出的卷积变分性AutoEncoder(CVAE)和替代特征提取方法。我们进一步表明,与仅当我们使用MRNA数据时,将MRNA,MicroRNA和DNA甲基化数据作为特征的功能提高了我们的模型的性能。此外,我们表明,在试图将原发性肿瘤与转移性的特征区别分解时,MRNA相关的特征在改造中进行更大的贡献。最后,我们表明我们的DL模型基于各种度量的机器学习(ML)集合方法显着优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号